The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug discovery. SEOUL, South Korea, /PRNewswire/ -- Portrai, Inc. today announced ...

Takara Bio USA, Inc. today announced a benchmark study comparing the performance of its Trekker® FX technology against ...

SEOUL, South Korea, April 8, 2026 /PRNewswire/ -- Portrai, Inc. today announced it will present 11 posters highlighting its artificial intelligence and spatial transcriptomics capabilities at the ...

On March 31, 2026, William Blair upgraded 10x Genomics from “Market Perform” to “Outperform,” highlighting its best-in-class genomics platforms and exposure to growing demand for large-scale ...

Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at Scale. Debuts at AACR Annual Meeting 2026 ...

Penn Medicine researchers will present advances in CAR T cell therapy, cancer interception, prevention, and more at the 2026 AACR Annual Meeting.

AutoNorm technology to optimize PCR amplification in real time, improving data quality and eliminating variability in ...

Understanding which cells within a tumor will go on to form metastases remains one of the major challenges in cancer research ...

Researchers from the Paris Brain Institute and Sainte-Justine University Hospital in Montreal have, for the first time, ...

Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.